Market Overview - The animal health sector experienced a decline of 0.53% on August 13, with Dayu Biological leading the drop [1] - The Shanghai Composite Index closed at 3683.46, up 0.48%, while the Shenzhen Component Index closed at 11551.36, up 1.76% [1] Individual Stock Performance - Key stocks in the animal health sector showed varied performance, with Xianfeng Holdings closing at 3.78, up 0.53%, and Dayu Biological closing at 9.84, down 3.15% [2][1] - Other notable stocks included Jinhe Biological at 7.45, down 3.12%, and Zhongmu Co. at 7.56, down 0.66% [2][1] Trading Volume and Value - The trading volume for Xianfeng Holdings was 268,700 shares with a transaction value of 102 million yuan, while Dayu Biological had a trading volume of 46,200 shares and a transaction value of 45.92 million yuan [2][1] Capital Flow Analysis - The animal health sector saw a net outflow of 175 million yuan from institutional investors, while retail investors contributed a net inflow of 143 million yuan [2][3] - The capital flow for specific stocks indicated that Hai Li Biological had a net inflow of 2.28 million yuan from institutional investors, while Xianfeng Holdings experienced a significant net outflow of 11.02 million yuan [3][2]

Investment Rating - The overall industry rating is "Positive" for the agriculture sector, indicating expected returns above the CSI 300 index by more than 5% in the next six months [6][51]. Core Views 1. **Livestock Industry Chain** - The swine market is experiencing rising epidemic risks and policy support, which is expected to enhance the motivation for capacity reduction. The average price of live pigs is currently 13.71 CNY/kg, down 0.62 CNY from last week, while the average price for 15 kg piglets is 31.24 CNY/kg, down 1.48 CNY [5][19]. - The operating rate of large-scale slaughterhouses has increased to 31.9%, up 0.36 percentage points from last week and 7.26 percentage points year-on-year. The total output of pigs from 16 listed companies reached 100.75 million heads, a year-on-year increase of 16.9% [5][19]. - The number of breeding sows has decreased to 40.43 million heads, down 370,000 from the peak last year. The average profit per head for self-bred pigs is 45 CNY, an increase of 2 CNY from last week [6][20]. 2. **Poultry Industry** - Chicken prices are experiencing fluctuations, with the average price for broiler chickens at 3.54 CNY/lb, up 0.13 CNY from last week. The average price for white feather chickens is 13.9 CNY/kg, up 0.2 CNY [21][23]. - The industry is at a historically high capacity level, with limited imports in the first seven months of the year. The profitability per chicken has turned positive at 0.62 CNY [21][23]. - The yellow chicken market is also seeing price declines, with average prices at 9.77 CNY/kg for Lihua yellow chicken, down 0.02 CNY from last month [23][24]. 3. **Seed and Planting Industry** - The seed industry is benefiting from ongoing policy optimization and the promotion of genetically modified organisms (GMOs). The long-term investment value of leading seed companies is highlighted as they are at historical low valuations [10][24]. - Grain prices are experiencing short-term adjustments but are expected to rise in the medium term due to reduced imports and adverse weather conditions. The average purchase price for corn is 2441 CNY/ton, down 4 CNY from last week [12][24]. Company Recommendations - Recommended companies include: - Zhongchong Co., Ltd. - Buy [3] - Muyuan Foods Co., Ltd. - Buy [3] - Suqian Agricultural Development Co., Ltd. - Buy [3]

Group 1 - The company, Ruipu Biological Co., Ltd., has announced the convening of its fourth extraordinary general meeting of shareholders for the year 2025, scheduled for August 25, 2025, at 14:30 [1] - Shareholders registered by the close of business on August 18, 2025, are entitled to attend the meeting and may appoint proxies to vote on their behalf [2] - The meeting will include non-cumulative voting proposals, and the results will be disclosed separately for small investors [5][10] Group 2 - Registration procedures for attending the meeting vary for corporate and individual shareholders, with specific documentation required for each [3][6] - Shareholders can participate in voting through both on-site and online platforms, with detailed instructions provided for the online voting process [7][8] - The company has provided contact information for inquiries related to the meeting, including phone and email details [7]

Group 1 - The company held its 21st temporary meeting of the fifth supervisory board on August 8, 2025, to discuss the continuation of its asset pool business [1][2] - The supervisory board believes that continuing the asset pool business will enhance the efficiency and returns of the company's assets, benefiting long-term development without harming the interests of the company and minority shareholders [1][2] - The company plans to engage in asset pool business with a total amount not exceeding 100 million RMB and provide guarantees, in compliance with relevant regulations [2] Group 2 - The voting results for the proposal were 3 votes in favor, 0 against, and 0 abstentions, indicating unanimous support from the supervisory board [2] - The proposal will be submitted for approval at the shareholders' meeting [2]

Group 1 - The company, Reap Bio (300119), announced that it will hold its fourth extraordinary general meeting of shareholders on August 25, 2025 [1] - The agenda for the meeting includes the proposal for the company and its subsidiaries to continue engaging in asset pool business and providing guarantees [1]

Group 1 - The company, Reap Bio, announced the convening of its 25th temporary board meeting on August 8, 2025, to discuss the proposal for the fourth temporary shareholders' meeting of 2025 [2] - For the year 2024, the revenue composition of Reap Bio is as follows: veterinary biological products account for 43.12%, veterinary drugs account for 33.86%, pet supply chain accounts for 20.63%, and others account for 2.38% [2]

一、担保情况概述 1、基本情况 证券代码：300119 证券简称：瑞普生物 公告编号：2025-060 瑞普生物股份有限公司 关于公司及子公司继续开展资产池业务并提供担保的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误 导性陈述或重大遗漏。 2024 年 3 月 8 日，公司第五届董事会第十二次（临时）会议及第五届监事 会第九次（临时）会议审议通过了《关于公司及子公司继续开展资产池业务并提 供担保的议案》，公司及部分分子公司与浙商银行股份有限公司天津分行（以下 简称"浙商银行天津分行"）开展总额不超过 1 亿元的资产池业务，有效期一年。 详见公司在 深 圳 证 券 交 易 所 网 站 （ http://www.szse.cn ） 及 巨 潮 资 讯 网 （http://www.cninfo.com.cn）披露的《关于公司及子公司继续开展资产池业务并 提供担保的公告》（公告编号：2024-010）。 为保障公司业务的连续性，盘活资产，提高流动资产的使用效率，公司及部 分分子公司，即：瑞普（天津）生物药业有限公司（以下简称"瑞普天津"）、 瑞普（保定）生物药业有限公司（以下简称" ...

证券代码：300119 证券简称：瑞普生物 公告编号：2025-061 关于召开 2025 年第四次临时股东大会的通知 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误 导性陈述或重大遗漏。 一、本次股东大会召开的基本情况 1、股东大会届次：2025年第四次临时股东大会 2、会议召集人：经公司第五届董事会第二十五次（临时）会议审议通过， 公司董事会决定召开2025年第四次临时股东大会。 3、会议召开的合法、合规性：本次股东大会的召集程序符合有关法律、行 政法规、部门规章、规范性文件和《公司章程》的规定。 4、会议召开时间： 现场会议召开时间：2025 年 8 月 25 日（星期一）14:30 瑞普生物股份有限公司 网络投票时间为： 通过深圳证券交易所交易系统进行网络投票的时间为2025年8月25日09:15- 09:25、09:30-11:30和13:00-15:00； 通过深圳证券交易所互联网系统投票的具体时间为2025年8月25日09:15- 15:00期间的任意时间。 5、会议的召开方式：本次股东大会采取现场投票与网络投票相结合的方 式。 （1）现场投票：包括本人出席及通过填写 ...

第五届监事会第二十一次（临时）会议决议公告 本公司及监事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误 导性陈述或重大遗漏。 一、监事会会议召开情况 瑞普生物股份有限公司（以下简称"公司"）第五届监事会第二十一次（临 时）会议于 2025 年 8 月 8 日在公司会议室以现场方式召开。会议通知于 2025 年 8 月 5 日以书面及网络方式送达全体监事。公司应出席监事 3 人，实际出席监事 3 人，参与表决监事 3 人。本次会议由周仲华先生主持。本次会议的召集、召开 和表决程序符合《公司法》《证券法》等法律法规和《公司章程》的规定。 二、监事会会议审议情况 1、审议通过了《关于公司及子公司继续开展资产池业务并提供担保的议案》 证券代码：300119 证券简称：瑞普生物 公告编号：2025-059 瑞普生物股份有限公司 具体内容详见公司于 2025 年 8 月 8 日披露于深圳证券交易所网站 （http://www.szse.cn）及巨潮资讯网（http://www.cninfo.com.cn）的《关于公司及 子公司继续开展资产池业务并提供担保的公告》。 表决结果：同意 3 票，反对 0 票，弃 ...

瑞普生物股份有限公司 第五届董事会第二十五次（临时）会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误 导性陈述或重大遗漏。 一、董事会会议召开情况 瑞普生物股份有限公司（以下简称"公司"）第五届董事会第二十五次（临 时）会议于 2025 年 8 月 8 日在公司会议室以现场结合通讯表决方式召开。会议 通知于 2025 年 8 月 5 日以书面及网络方式送达全体董事。公司应出席董事 9 人， 实际出席董事 9 人，参与表决董事 9 人（其中董事李睿、杨鶄，独立董事郭春林、 才学鹏、李娅以通讯方式参会）。本次会议由董事长李守军先生主持，公司高级 管理人员列席了会议。本次会议的召集、召开和表决程序符合《公司法》《证券 法》等法律法规和《公司章程》的规定。 证券代码：300119 证券简称：瑞普生物 公告编号：2025-058 公司参与资产池业务主体有：分公司、全资子公司及控股子公司，具有较为 充足的偿还债务能力，公司能够对其实施有效的业务、资金管理和风险控制，对 其提供担保不会影响公司主营业务的正常开展。控股子公司龙翔药业提供反担保， 此次资产池业务的财务风险处于公司可控的范 ...